Categories
Archives
Receive Email Updates
-
-
-
Certified Licensing Professionals, Inc., 2021 
Disclaimer
This blog, Patents4Life, does not contain legal advice and is for informational purposes only. Its publication does not create an attorney-client relationship nor is it a solicitation for business. This is the personal blog of Warren Woessner and does not reflect the views of Schwegman Lundberg & Woessner, or any of its attorneys or staff. To the best of his ability, the Author provides current and accurate information at the time of each post, however, readers should check for current information and accuracy.
-
- About Me
Warren D. Woessner
Pages
Archives
Tag Archives: biotechnology appeal
Supreme Court Grants Cert. In Caraco
Today (June 27, 2010), the Supreme Court granted cert. in yet another patent appeal, Caraco Pharm. Labs., Ltd., v. Novo Nordisk, (Supreme Ct. 10-844). Earlier this month, I did an extensive post on the decision below, in which the Fed. … Continue reading
Appeals Court Overturns Stem Cell Ban
On April 29th, in Sherley v. Sebelius, the U.S. Court of Appeals for the D.C. Cir., (a copy is available at the end of this post) overturned the injunction imposed by the district court, which had blocked the implementation of … Continue reading
Posted in Stem Cells/Cloning
Tagged biotechnology, biotechnology appeal, biotechnology law, biotechnology news, court of appeals, dickey-wicker, executive order 13505, Federal Circuit, intellectual property, ip, NIH, Patent Law, patents, sebelius, sherley, stem cell research, stem cells, Warren Woessner
Leave a comment
ACLU Files Its Brief in Myriad – Argues DNA Is A Blueprint Without a Name
On November 30, 2010, the ACLU filed its brief at the Federal Circuit in AMP et al. v. USPTO and Myriad Genetics, Inc. et al. If you have been reading my posts on this suit, you are by now probably … Continue reading
UNIVERSITY OF PITTSBURGH v. HEDRICK – ON A (CLEAR) CONCEPTION DAY
From a prosecutor’s standpoint, the ‘231 patent (link at bottom of this post) has “dream claims” to a new class of stem cells. Claim 1 reads: An isolated adipose-derived stem cell that can differentiate into two or more of the … Continue reading